181 related articles for article (PubMed ID: 16596266)
1. Apolipoprotein-E modulates the cytotoxic effect of beta-amyloid on rat brain endothelium in an isoform-dependent specific manner.
Folin M; Baiguera S; Guidolin D; Di Liddo R; Grandi C; De Carlo E; Nussdorfer GG; Parnigotto PP
Int J Mol Med; 2006 May; 17(5):821-6. PubMed ID: 16596266
[TBL] [Abstract][Full Text] [Related]
2. Effects of beta-amyloid on rat neuromicrovascular endothelial cells cultured in vitro.
Folin M; Baiguera S; Tommasini M; Guidolin D; Conconi MT; De Carlo E; Nussdorfer GG; Parnigotto PP
Int J Mol Med; 2005 Jun; 15(6):929-35. PubMed ID: 15870895
[TBL] [Abstract][Full Text] [Related]
3. Interaction of nascent ApoE2, ApoE3, and ApoE4 isoforms expressed in mammalian cells with amyloid peptide beta (1-40). Relevance to Alzheimer's disease.
Aleshkov S; Abraham CR; Zannis VI
Biochemistry; 1997 Aug; 36(34):10571-80. PubMed ID: 9265639
[TBL] [Abstract][Full Text] [Related]
4. Isoform-specific effect of apolipoprotein E on endocytosis of beta-amyloid in cultures of neuroblastoma cells.
Yamauchi K; Tozuka M; Hidaka H; Nakabayashi T; Sugano M; Katsuyama T
Ann Clin Lab Sci; 2002; 32(1):65-74. PubMed ID: 11848621
[TBL] [Abstract][Full Text] [Related]
5. Isoform-specific interactions of human apolipoprotein E to an intermediate conformation of human Alzheimer amyloid-beta peptide.
Stratman NC; Castle CK; Taylor BM; Epps DE; Melchior GW; Carter DB
Chem Phys Lipids; 2005 Oct; 137(1-2):52-61. PubMed ID: 16140289
[TBL] [Abstract][Full Text] [Related]
6. Apolipoprotein E allele-specific antioxidant activity and effects on cytotoxicity by oxidative insults and beta-amyloid peptides.
Miyata M; Smith JD
Nat Genet; 1996 Sep; 14(1):55-61. PubMed ID: 8782820
[TBL] [Abstract][Full Text] [Related]
7. ApoE isoform-specific effects on LTP: blockade by oligomeric amyloid-beta1-42.
Trommer BL; Shah C; Yun SH; Gamkrelidze G; Pasternak ES; Stine WB; Manelli A; Sullivan P; Pasternak JF; LaDu MJ
Neurobiol Dis; 2005 Feb; 18(1):75-82. PubMed ID: 15649697
[TBL] [Abstract][Full Text] [Related]
8. Aging, gender and APOE isotype modulate metabolism of Alzheimer's Abeta peptides and F-isoprostanes in the absence of detectable amyloid deposits.
Yao J; Petanceska SS; Montine TJ; Holtzman DM; Schmidt SD; Parker CA; Callahan MJ; Lipinski WJ; Bisgaier CL; Turner BA; Nixon RA; Martins RN; Ouimet C; Smith JD; Davies P; Laska E; Ehrlich ME; Walker LC; Mathews PM; Gandy S
J Neurochem; 2004 Aug; 90(4):1011-8. PubMed ID: 15287908
[TBL] [Abstract][Full Text] [Related]
9. A 13 kDa carboxy-terminal fragment of ApoE stabilizes Abeta hexamers.
Wellnitz S; Friedlein A; Bonanni C; Anquez V; Goepfert F; Loetscher H; Adessi C; Czech C
J Neurochem; 2005 Sep; 94(5):1351-60. PubMed ID: 16011742
[TBL] [Abstract][Full Text] [Related]
10. Higher avidity binding of apolipoprotein (E-AII) complex than of apolipoprotein E monomer to beta-amyloid.
Yamauchi K; Tozuka M; Nakabayashi T; Sugano M; Hidaka H; Kondo Y; Katsuyama T
J Neurosci Res; 1999 Oct; 58(2):301-7. PubMed ID: 10502286
[TBL] [Abstract][Full Text] [Related]
11. Caspase-8 activation and oxidative stress are involved in the cytotoxic effect of beta-amyloid on rat brain microvascular endothelial cells.
Folin M; Baiguera S; Fioravanzo L; Conconi MT; Grandi C; Nussdorfer GG; Parnigotto PP
Int J Mol Med; 2006 Mar; 17(3):431-5. PubMed ID: 16465389
[TBL] [Abstract][Full Text] [Related]
12. A nontransgenic mouse model shows inducible amyloid-beta (Abeta) peptide deposition and elucidates the role of apolipoprotein E in the amyloid cascade.
Dolev I; Michaelson DM
Proc Natl Acad Sci U S A; 2004 Sep; 101(38):13909-14. PubMed ID: 15365176
[TBL] [Abstract][Full Text] [Related]
13. Contribution of cysteine 158, the glycosylation site threonine 194, the amino- and carboxy-terminal domains of apolipoprotein E in the binding to amyloid peptide beta (1-40).
Aleshkov SB; Li X; Lavrentiadou SN; Zannis VI
Biochemistry; 1999 Jul; 38(28):8918-25. PubMed ID: 10413465
[TBL] [Abstract][Full Text] [Related]
14. Attenuation of the neurotoxic effect of A beta amyloid peptide by apolipoprotein E.
Whitson JS; Mims MP; Strittmatter WJ; Yamaki T; Morrisett JD; Appel SH
Biochem Biophys Res Commun; 1994 Feb; 199(1):163-70. PubMed ID: 8123007
[TBL] [Abstract][Full Text] [Related]
15. Association of human, rat, and rabbit apolipoprotein E with beta-amyloid.
LaDu MJ; Lukens JR; Reardon CA; Getz GS
J Neurosci Res; 1997 Jul; 49(1):9-18. PubMed ID: 9211985
[TBL] [Abstract][Full Text] [Related]
16. An apolipoprotein E-based therapeutic improves outcome and reduces Alzheimer's disease pathology following closed head injury: evidence of pharmacogenomic interaction.
Wang H; Durham L; Dawson H; Song P; Warner DS; Sullivan PM; Vitek MP; Laskowitz DT
Neuroscience; 2007 Feb; 144(4):1324-33. PubMed ID: 17187933
[TBL] [Abstract][Full Text] [Related]
17. In vitro apolipoprotein E protects human red blood cells against lysis induced by amyloid-beta (AP) fragment 25-35.
Galeazzi L; Corder EH; Galeazz R; Casoli T; Valli MB; Giunta S
Amyloid; 2002 Jun; 9(2):103-7. PubMed ID: 12440482
[TBL] [Abstract][Full Text] [Related]
18. ApoE protects cortical neurones against neurotoxicity induced by the non-fibrillar C-terminal domain of the amyloid-beta peptide.
Drouet B; Fifre A; Pinçon-Raymond M; Vandekerckhove J; Rosseneu M; Guéant JL; Chambaz J; Pillot T
J Neurochem; 2001 Jan; 76(1):117-27. PubMed ID: 11145984
[TBL] [Abstract][Full Text] [Related]
19. Gene delivery of human apolipoprotein E alters brain Abeta burden in a mouse model of Alzheimer's disease.
Dodart JC; Marr RA; Koistinaho M; Gregersen BM; Malkani S; Verma IM; Paul SM
Proc Natl Acad Sci U S A; 2005 Jan; 102(4):1211-6. PubMed ID: 15657137
[TBL] [Abstract][Full Text] [Related]
20. Intraneuronal amyloid-beta plays a role in mediating the synergistic pathological effects of apoE4 and environmental stimulation.
Levi O; Dolev I; Belinson H; Michaelson DM
J Neurochem; 2007 Nov; 103(3):1031-40. PubMed ID: 17666042
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
